COVID-19 clinical research pages
The COVID-19 crisis requires researchers to join forces worldwide to find a cure and a vaccine, and sharing research data is a critical step in this global cooperation effort. In this context, ECRIN has published COVID-19 clinical research pages with its national partners:
- Review and digest the scientific literature on COVID clinical trials
- Develop a metadata repository for COVID trials making all the non-sensitive COVID-19 trial data accessible
- Develop a database on the regulatory, ethical and data protection fast track approvals across all European countries
- Ensure preparedness of its national clinical trial unit (CTU) partners for COVID trials
- Combine and coordinate national initiatives to promote multinational rather than national trials, including through connection with national funders, sponsors investigators and CTUs
- Develop partnership with national and pan-European investigation networks on infectious diseases and intensive care
- Outreach to investigators, sponsors, patients, policymakers, funders, and citizens
- International cooperation and outreach, including with WHO and through CRIGH and other initiatives
Discover ECRIN's response to boost Covid-19 research
ECRIN shares a curated list of the most relevant articles presenting results from COVID19 trials, including pre-prints.
Discover the Covid-19 Literature review.
This list of calls for funding for COVID19 is curated by ECRIN and updated on a monthly basis.
Discover the Covid-19 funding calls.
Most of the European countries have put in place accelerated procedures (“Fast track” procedure) for the evaluation and authorisation of clinical trials related to the management of the pandemic COVID-19.
Discover the Covid-19 fast track procedures.
Hundreds of clinical trials of potential COVID-19 treatments and interventions have been launched worldwide.
Discover the Covid-19 clinical trial registries.
For any further information please contact ECRIN’s Head of Clinical Operations Unit, Sabine Kläger via mail.
Legal disclaimer for the COVID-19 clinical research pages.